Shedding New Light on the Magnitude of Thrombosis Risk in Patients With Myeloproliferative Neoplasms

In this issue, Hultcrantz and colleagues report a study that examined thrombosis patterns in Swedish patients with myeloproliferative neoplasms (MPNs) diagnosed between 1987 and 2009 compared with matched control participants. The editorialists discuss the implications of the study's findings and highlight the keys to a personalized, precision medicine approach to primary and secondary thrombosis prevention for patients with MPNs.

http://ift.tt/2mzvxKF